07:56 AM EST, 12/11/2025 (MT Newswires) -- Aurora Cannabis (ACB.TO) said Thursday it is launching Black Jelly, a proprietary cultivar, in Poland, expanding its portfolio of high-potency medical cannabis products there.

Black Jelly will be available for Polish prescribers from today, Dec. 11, 2025, offering a cannabinoid profile of THC 27% / CBD <1%.

"Aurora is uniquely positioned to bring this novel proprietary cultivar to the Polish market thanks to the company's advanced genetic breeding program and unmatched global cultivation excellence," said Andreas Dotterweich, Aurora Europe's senior vice president. "We deeply understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we're proud to offer superior products that consistently meet prescriber and patient needs."

Aurora Cannabis shares are up US$0.01, to $4.54, in U.S. pre-market trading.

http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.